Sunovion Pharmaceuticals Inc.
USPTO PatentsView assignee record - 88 granted patents across 20 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Sunovion ranks #4,100 of 49,997 tracked US assignees by granted-patent volume, with 88 patents across 20 technology areas.
- #4,100
- of 49,997 US assignees by volume
- Top 19%
- by Innovation Score (47.1/100)
- 22.6
- avg claims per patent
- -20%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4100 · US Corporation #4,100 · 88 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 88 grants
- TOP-DECILE #4,100/49,997
- PHOTO-FINISH O2Micro
- CPC-FOCUS A61P · 20 areas
- INNOV-PAR 47.1/100
- CLAIMS-DENSE 22.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -20% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: O2Micro Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Sunovion’s 47.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Sunovion
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- QuantumScape · near
QuantumScape · near
47 score
- Areva · near
Areva · near
47 score
- KIP Prod P1 · near
KIP Prod P1 · near
47 score
- Sunovion Pharmaceuti… · this assignee
Sunovion Pharmaceuti… · this assignee
47 score
- Vizio · near
Vizio · near
47 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Sunovion's Innovation Score is 47.1/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Sunovion?
Each dot is one of Sunovion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sunovion’s own 22.6 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Sunovion's grants concentrate
Sunovion Pharmaceuticals Inc. is a focused PatentsView assignee: 20 CPC subclasses with 84.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (16 grants) versus a trough of 2 in 2024. By volume, Sunovion sits between O2Micro Inc. and Basf Agricultural Solutions Seed US LLC.
Sunovion's three-year grant acceleration
From 2019–2021 to 2022–2024, Sunovion Pharmaceuticals Inc. moved from 38 to 13 grants (0.34x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Sunovion's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- O2micro
O2Micro Inc.
88 patents
- Purecircle Sdn Bhd
PureCircle Sdn Bhd
88 patents
- Qatar Foundation…
Qatar Foundation FOR Education, Science AND Community Development
88 patents
- Ricoh Imaging
Ricoh Imaging Company, Ltd.
88 patents
- Tactotek OY
Tactotek OY
88 patents
- Toray Plastics (A…
Toray Plastics (America), Inc.
88 patents
- WIN Semiconductors
WIN Semiconductors Corp.
88 patents
- Sunovion Pharmace… ◀
Sunovion Pharmaceuticals Inc.
88 patents
- Basf Agricultural…
Basf Agricultural Solutions Seed US LLC
87 patents
What this shows Sunovion holds 88 patents at rank #4,100, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Sunovion
By rank, the assignees closest to #4,100 in granted patent volume.
- O2Micro Inc. #4,096 · 88 patents
- PureCircle Sdn Bhd #4,097 · 88 patents
- Qatar Foundation FOR Education, Science AND Community Development #4,098 · 88 patents
- Ricoh Imaging Company, Ltd. #4,099 · 88 patents
- Tactotek OY #4,101 · 88 patents
- Toray Plastics (America), Inc. #4,102 · 88 patents
- WIN Semiconductors Corp. #4,103 · 88 patents
- Basf Agricultural Solutions Seed US LLC #4,104 · 87 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Sunovion's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Sunovion, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Sunovion ranks #229 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (47 here).
Similar claim depth
Nearest assignees by average claims per patent (22.6 here).
Sunovion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 9.1% |
| 2016 | 7 | 8.0% |
| 2017 | 11 | 12.5% |
| 2018 | 11 | 12.5% |
| 2019 | 12 | 13.6% |
| 2020 | 16 | 18.2% |
| 2021 | 10 | 11.4% |
| 2022 | 8 | 9.1% |
| 2023 | 3 | 3.4% |
| 2024 | 2 | 2.3% |
Which technologies does Sunovion Pharmaceuticals Inc. patent most?
Top 15 of 20 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Sunovion Pharmaceuticals Inc.'s patent record in context - here's where to go next.
- Sunovion Pharmaceuticals Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.1% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #4,100 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Sunovion Pharmaceuticals Inc. against O2Micro Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 47.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.